Skip to main content
Caplight Logo









Navignostics AG

Navignostics AG

Private
HorgenHealthcare & Life Scienceshttps://www.navignostics.com/

Last Round

Seed

Nov 9, 2022

Total Funding Raised

$8.69M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Navignostics AG is a precision oncology company that provides spatial single-cell proteomics analysis to guide personalized cancer treatment and accelerate drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

spatial proteomicssingle-cell analysisspatial omicstumor microenvironmentspatial biologydrug discoveryprecision medicinebiomarker identificationhigh-plex imagingtumor heterogeneityclinical trial developmenttranslational researchcompanion diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Navignostics AG Comparables

Compare Navignostics AG with similar companies based on industry and business-model similarity.

Navignostics AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sirona Dx
86%
Explicyte Immuno-Oncology
80%
Propath (UK) Limited
79%

Navignostics AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 9, 2022
Convertible DebtAug 29, 2022

Key People

Founding team and executive leadership

Andrea Jacobs

Co-Founder, COO

Founding Team

Christoph Schäfer

Fractional CFO

Executive Team

Navignostics AG Investors

Notable investors and investment history

Navignostics AG investors
InvestorRounds
Think.HealthSeed
Ventura BioMed InvestorsSeed
Zurcher KantonalbankSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 273% MoM.

  • Mar 3, 2026

    Monthly visitors grew 285% MoM, reaching 3.9K.

Navignostics AG Filings

Explore SEC and related filing metadata, where available.

Navignostics AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Navignostics AG's valuation, stock price, and market status.

Is Navignostics AG a public or private company?

Navignostics AG is a private company.

What is the current stock price of Navignostics AG?

Navignostics AG is a private company with no public stock price. No recent secondary market data is available.

How much is Navignostics AG worth (valuation)?

Valuation information for Navignostics AG is not publicly available.

Can I buy Navignostics AG stock?

Navignostics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Navignostics AG's last funding round?

Navignostics AG's most recent funding round was Seed on November 9, 2022.

Who are the main investors in Navignostics AG?

Key investors in Navignostics AG include Think.Health, Ventura BioMed Investors, Zurcher Kantonalbank.

Will Navignostics AG IPO soon?

No public IPO plans have been announced for Navignostics AG.

How can I track Navignostics AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Navignostics AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHorgen
Employee Range13
Year Founded2022
Last FundingNov 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?